Mottiwala Aziz (CIK 1788542) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-19). Recent activity: Sell TARS (4,286 shares), Sell TARS (4,330 shares), Sell TARS (4,440 shares), Buy TARS (26,482 shares), Sell TARS (17,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Commercial Officer | Sell | 4,286 | $297,534 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Commercial Officer | Sell | 4,330 | $297,514 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Commercial Officer | Sell | 4,440 | $297,480 |
| 2026-03-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Commercial Officer | Buy | 26,482 | $0 |
| 2025-06-11 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Commercial Officer | Sell | 17,500 | $765,800 |
来源：SEC Form 4 申报文件 · 截至 2026-03-19